Nanfang Hospital, Southern Medical University
Clinical trials sponsored by Nanfang Hospital, Southern Medical University, explained in plain language.
-
New drug combo aims to tame lupus kidney disease in kids
Disease control Not yet recruitingThis study tests whether combining rituximab with a low dose of mycophenolate mofetil can safely and effectively treat lupus nephritis in children. Lupus nephritis is a serious kidney complication of lupus. The trial enrolls children aged 3 to 18 with active kidney inflammation. …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
New drug aims to boost red blood cells after transplant
Disease control Not yet recruitingThis study compares luspatercept to epoetin for patients with blood cancers who have poor red blood cell recovery after a stem cell transplant. About 90 adults will receive either drug every three weeks for 24 weeks. The goal is to see which treatment better reduces the need for …
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for kidney patients: drug aims to prevent relapse
Disease control Not yet recruitingThis study tests whether a 15-month course of Nefecon can prevent proteinuria relapse in 288 adults with IgA nephropathy who have already achieved remission. Participants must have completed prior Nefecon therapy and have stable kidney function. The goal is to see if maintenance …
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Which stroke drug is safest? 2,000-patient study aims to find out
Disease control Not yet recruitingThis study looks at 2,000 people who had a stroke to see which blood-thinning medicine works best to stop another stroke. The drugs being compared are indobufen, aspirin, cilostazol, and clopidogrel, used alone or in pairs. Researchers will track strokes and bleeding problems for…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Tailored therapy after stomach cancer surgery could boost survival
Disease control Not yet recruitingThis study looks at whether changing the type of chemotherapy after stomach cancer surgery can help people live longer. It involves 405 adults who had chemotherapy and immunotherapy before surgery. Depending on how much cancer remained after surgery, some will get a different tre…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could blood pressure pills boost stomach cancer treatment?
Disease control Not yet recruitingThis study looks at whether adding a common blood pressure medication (beta-blocker) to standard immunotherapy can help shrink stomach cancer before surgery. It will include 33 adults with high blood pressure and locally advanced stomach cancer. The goal is to see if the combinat…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy aims to control breast cancer brain metastases
Disease control Not yet recruitingThis study tests whether combining brain radiation with a targeted drug (dalpiciclib) and hormone therapy can help control breast cancer that has spread to the brain in people with HR-positive/HER2-negative disease. About 46 participants will receive the combination and be follow…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a herbal capsule slash liver cancer risk in hepatitis b patients?
Disease control Not yet recruitingThis study tests whether adding Babao Dan Capsule (a traditional Chinese medicine) to standard antiviral treatment can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis who are at high risk. About 1,034 adults aged 18-65 with a specific TCM …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to stop anemia after stem cell transplants
Disease control Not yet recruitingThis study tests whether the drug luspatercept can prevent severe anemia (low red blood cells) after a stem cell transplant in people with blood cancers and a bone marrow condition called myelofibrosis. About 196 adults will receive either luspatercept or standard supportive care…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New triple combo aims to tackle Hard-to-Treat liver cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few other spots and no longer responds to first-line treatment. The goal is to see if this triple therapy can slow …
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for stroke patients with cancer: antioxidant drug trial launches
Disease control Not yet recruitingThis study tests whether a drug called edaravone dexborneol can help people who have a stroke while also having active cancer. The drug is given by IV twice a day for 10-14 days. Researchers will check if it improves recovery and is safe. About 144 adults aged 18-80 will take par…
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common drug prevent brain swelling after stroke?
Disease control Not yet recruitingThis study tests whether the drug butylphthalide can reduce brain swelling in people who have had a severe stroke and undergone a procedure to reopen a blocked artery. About 100 adults will receive either the drug or a placebo for up to 14 days. Researchers will measure changes i…
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Herbal compound may cut liver cancer risk in High-Risk hepatitis b patients
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese medicine called Biejia-Ruangan compound to standard antiviral therapy can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis. About 1,034 high-risk adults (based on a special score) will b…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to prevent dangerous transplant complication in rare blood cancer
Disease control Not yet recruitingThis study tests whether a new drug called gecacitinib, combined with standard anti-rejection medicine, can prevent a serious complication called graft-versus-host disease (GVHD) in people with myelofibrosis who receive a stem cell transplant. About 40 adults will take part. The …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a simple gas save lives in severe lung failure?
Disease control Not yet recruitingThis study tests whether adding inhaled nitric oxide (iNO) to standard care helps adults with moderate-to-severe acute respiratory distress syndrome (ARDS) survive longer. About 536 participants will be randomly assigned to receive iNO or a placebo through their ventilator. The m…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail aims to wipe out lingering leukemia
Disease control Not yet recruitingThis study tests whether combining two oral drugs, sorafenib and venetoclax, can eliminate leftover leukemia cells in people with acute myeloid leukemia (AML) who still have measurable residual disease (MRD) after initial treatment. About 87 participants will receive the drugs fo…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for kids with hepatitis b: interferon trial aims for functional cure
Disease control Not yet recruitingThis study tests whether a weekly injection of pegylated interferon alfa-2b for 48 weeks can help children and teens (ages 3–17) with chronic hepatitis B achieve a functional cure. The treatment group will be compared to an observation group receiving no drug or standard antivira…
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a cholesterol drug boost stroke recovery?
Disease control Not yet recruitingThis study tests whether adding a PCSK9 inhibitor (a cholesterol-lowering drug) to standard care helps people recover better after a stroke caused by a blocked artery. About 478 adults who had a stroke and received a procedure to reopen the blocked vessel will be randomly assigne…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:12 UTC
-
Glowing probe could help surgeons spot stomach cancer edges
Diagnosis Not yet recruitingThis study tests a new fluorescent dye that attaches to cancer cells, helping surgeons see exactly where a stomach tumor ends during surgery. The probe is tested on freshly removed stomach tissue from 32 patients. If successful, it could lead to more precise cancer removal and fe…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Can a simple pill help liver cancer patients eat better?
Symptom relief Not yet recruitingThis Phase 2 trial tests whether a drug called nanocrystalline megestrol acetate can help people with advanced liver cancer who are losing weight and appetite. About 88 patients will receive either the drug or a placebo for 12 weeks while also getting standard cancer therapy. The…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
AI reads your social media to boost breast cancer mental health
Symptom relief Not yet recruitingThis study tests whether an AI system that analyzes social media posts can improve quality of life for breast cancer patients. 440 women will either use the AI system plus usual care or just usual care for 6 months. The goal is to see if personalized emotional support reduces anx…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
AI vs. doctor: who diagnoses better?
Knowledge-focused Not yet recruitingThis study will see if using an AI model helps pathologists (doctors who diagnose diseases from tissue samples) work better. Over 2000 patients will have their cases reviewed by pathologists, some using AI assistance and some not. The goal is to compare accuracy, speed, and confi…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
AI eye in the colon: new study aims to catch hidden polyps
Knowledge-focused Not yet recruitingThis study tests whether a computer-aided detection system can help doctors find more polyps in the right side of the colon during a colonoscopy. About 686 adults aged 40-75 will have two colonoscopies in one session, with the AI system used in one of them. The goal is to see if …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can better nutrition help kids with brain tumors feel better during radiation?
Knowledge-focused Not yet recruitingThis study follows 93 children aged 5-18 with brain tumors who are receiving radiation therapy. Researchers will track their nutrition and quality of life over time to see how they are connected. The goal is to create a nutrition plan and early warning system to help these childr…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC